- Home
- / Singular Genomics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Singular Genomics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$13.6
2024-10-29
Market Capitalization
$33.9 M
2024-10-29
Revenue
$2.9 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 24, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 765.0K | 2.9M | |
| Cost of goods sold | 789.0K | 3.5M | |
| Gross profit | (24.0K) | (558.0K) | |
| General and administrative expense | 28.6M | 47.3M | 54.5M |
| Operating expense total | 61.3M | 93.5M | 102.2M |
| EBIT | (61.3M) | (93.5M) | (102.8M) |
| Interest income | 328.0K | 3.4M | 9.1M |
| Interest expense | 846.0K | 763.0K | 1.1M |
| Net Income | (98.8M) | (90.9M) | (94.8M) |
| EPS | (2.1) | (1.0) | (1.0) |